NAMA JUMLAH PASIEN JUMLAH PERSEN

NO
OBAT Oktober November
Amoksilli
n+asam
1 3 - 3 0,16%
klavulana
t
Ampicilli
2 n+sulbact 6 24 30 1.59%
am
Azytromi
3 1 1 2 0,11%
sin
4 Cefixime 335 210 545 28,87%
Cefadroxi
5 3 1 4 0,21%
l
Cefopera
6 4 1 5 0,26%
zone
Cefotaxi
7 12 1 13 0,69%
me
Ceftazidi
8 - 1 1 0,05%
me
Ceftriaxo
9 544 647 1191 63,08%
n
Cefuroxi
10 10 22 32 1,69%
me
Clindami
11 1 - 1 0,05%
sin
Ciproflox
13 1 1 2 0,11%
acin
Gentamis
15 7 7 14 0,74%
in
Kloramfe
17 2 1 3 0,16%
nikol
Levoflox
18 12 12 24 1,27%
acin
Metronid
19 7 5 12 0,64%
azol
Meropene
20 3 3 6 0,32%
m
TOTAL 1888 100%
NAMA OBAT PRESENTASE
Amoksillin+asam
0.16%
klavulanat
Ampicillin+sulbactam 1.59%
Azytromisin 0.11%
Cefixime 28.87% PENGGUNAAN ANTIBIOT
Cefadroxil 0.21%
Cefoperazone 0.26% 70.00%
Cefotaxime 0.69% 60.00%
Ceftazidime 0.05% 50.00%
Ceftriaxon 63.08% 40.00%
Cefuroxime 1.69% 30.00%
Clindamisin 0.05% 20.00%
Ciprofloxacin 0.11% 10.00%
Gentamisin 0.74%
0.00%
Kloramfenikol 0.16% e xi l ne
at m i n e e on e
Levofloxacin 1.27% l a n a cta mi s fxi m dro a zo axi m i di m i ax oxi m mi s
u r t z r r
Metronidazol 0.64% av l b tro Ce Cefa ope efo efa Cef efu i nda
kl +s u Azy fe C C C Cl p
Meropenem 0.32% am ill in C Ci
a s c
l i n+ pi
s il Am
ok
Am

Tot
DDD/ra
NO Kode DDD Nama antibiotik Tot DDD
wat inap
*100
1 J01DD04 Ceftriaxone iv 444 66,66
2 J01MA12 Levofloxacin iv - -
3 J01GB03 Gentamycin iv - -
4 J01XD01 Metronidazole iv - -
5 J01DD01 Cefotaxim iv - -
6 J01DC02 Cefuroxime iv - -
7 J01DH02 Meropenem iv - -
8 J01DD08 Cefixim po 96 14,41
9 J01DD12 Cefoperazon iv - -
J01CR01 Ampisilin
10 - -
&Sulbaktam iv
AAN ANTIBIOTIK RAWAT INAP

PRESENTASE

e e e n e n n n l n zol em
on i m i m xo i m i s i ci i s i i ko ci
a z tax zi d ri a rox a m oxa a m fen oxa ni da pen
fo a ef fu d f nt m f o ro
Ce Cef C Ce l i n i pro Ge ora Levo etr Me
C C Kl M